FUS and surfactant-based nanocarriers: A combined strategy for nose to brain drug delivery

Misra, 2003, Drug delivery to the central nervous system: a review, J. Pharm. Pharmaceut. Sci., 6, 252 Bozdağ Pehlivan, 2013, Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases, Pharm. Res. (N. Y.), 30, 2499, 10.1007/s11095-013-1156-7 Abbott, 2013, Blood–brain barrier structure and function and the challenges for CNS drug delivery, J. Inherit. Metab. Dis., 36, 437, 10.1007/s10545-013-9608-0 Furtado, 2018, Overcoming the blood–brain barrier: the role of nanomaterials in treating neurological diseases, Adv. Mater., 30, 1801362, 10.1002/adma.201801362 Patel, 2017, Crossing the blood-brain barrier: recent advances in drug delivery to the brain, CNS Drugs, 31, 109, 10.1007/s40263-016-0405-9 Zhang, 2021, Reduced synaptic transmission and intrinsic excitability of a subtype of pyramidal neurons in the medial prefrontal cortex in a mouse model of Alzheimer's disease, JAD, 84, 129, 10.3233/JAD-210585 Keller, 2022, Intranasal drug delivery: opportunities and toxicologic challenges during drug development, Drug Deliv. and Transl. Res., 12, 735, 10.1007/s13346-020-00891-5 Pires, 2018, Nanosystems in nose-to-brain drug delivery: a review of non-clinical brain targeting studies, J. Contr. Release, 270, 89, 10.1016/j.jconrel.2017.11.047 Lee, 2021, Nanotherapeutics for nose-to-brain drug delivery: an approach to bypass the blood brain barrier, Pharmaceutics, 13, 2049, 10.3390/pharmaceutics13122049 Kumar, 2016, Relative vascular permeability and vascularity across different regions of the rat nasal mucosa: implications for nasal physiology and drug delivery, Sci. Rep., 6, 31732, 10.1038/srep31732 Aly, 2019, Intranasal delivery of hGDNF plasmid DNA nanoparticles results in long-term and widespread transfection of perivascular cells in rat brain, Nanomedicine, 16, 20, 10.1016/j.nano.2018.11.006 Formica, 2022, On a highway to the brain: a review on nose-to-brain drug delivery using nanoparticles, Appl. Mater. Today, 29, 101631, 10.1016/j.apmt.2022.101631 Barbato, 2022, Exploiting focused ultrasound to aid intranasal drug delivery for brain therapy, Front. Pharmacol., 13, 786475, 10.3389/fphar.2022.786475 Chai, 2014, Magnetic-resonance imaging for kinetic analysis of permeability changes during focused ultrasound-induced blood-brain barrier opening and brain drug delivery, J. Contr. Release, 192, 1, 10.1016/j.jconrel.2014.06.023 Chen, 2015, Focused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study, J. Transl. Med., 13, 93, 10.1186/s12967-015-0451-y Chen, 2014, A new brain drug delivery strategy: focused ultrasound-enhanced intranasal drug delivery, PLoS One, 9 Ye, 2018, Focused ultrasound combined with microbubble-mediated intranasal delivery of gold nanoclusters to the brain, J. Contr. Release, 286, 145, 10.1016/j.jconrel.2018.07.020 Hanieh, 2022, Ultrastable shelled PFC nanobubbles: a platform for ultrasound-assisted diagnostics, and therapy, Nanomed. Nanotechnol. Biol. Med., 46, 102611, 10.1016/j.nano.2022.102611 Negishi, 2015, Enhancement of blood–brain barrier permeability and delivery of antisense oligonucleotides or plasmid DNA to the brain by the combination of bubble liposomes and high-intensity focused ultrasound, Pharmaceutics, 7, 344, 10.3390/pharmaceutics7030344 Lin, 2013, Acoustic droplet vaporization in biology and medicine, BioMed Res. Int., 2013, 404361, 10.1155/2013/404361 Serbest, 2006, Mechanisms of cell death and neuroprotection by poloxamer 188 after mechanical trauma, Faseb. J., 20, 308, 10.1096/fj.05-4024fje Pitto-Barry, 2014, Pluronic® block-copolymers in medicine: from chemical and biological versatility to rationalisation and clinical advances, Polym. Chem., 5, 3291, 10.1039/C4PY00039K De Castro, 2023, Pluronic® triblock copolymer-based nanoformulations for cancer therapy: a 10-year overview, J. Contr. Release, 353, 802, 10.1016/j.jconrel.2022.12.017 Katti, 2012, A one-step electrospray-based technique for modulating morphology and surface properties of poly(lactide-co-glycolide) microparticles using Pluronics®, IJN, 5129, 10.2147/IJN.S34185 Kontogiannis, 2022, Non-ionic surfactant effects on innate pluronic 188 behavior: interactions, and physicochemical and biocompatibility studies, IJMS, 23, 13814, 10.3390/ijms232213814 Nascimento, 2022, Influência do Parâmetro de Equilíbrio Hidrofílico- Hidrofóbico (HLB) dos Polímeros F98 e F127 na eficácia da formação de nanopartículas de ouro e encapsulamento do fármaco capecitabina para tratamento de câncer de estomâgo, RSD, 11 Ag Seleci, 2016, Niosomes as nanoparticular drug carriers: fundamentals and recent applications, J. Nanomater., 2016, 1, 10.1155/2016/7372306 Haj-Ahmad, 2015, In vitro characterisation of Span™ 65 niosomal formulations containing proteins, CDD, 12, 628, 10.2174/1567201812666150511095432 Carluccio, 1999, Oleic acid inhibits endothelial activation : a direct vascular antiatherogenic mechanism of a nutritional component in the mediterranean diet, Arterioscler. Thromb. Vasc. Biol., 19, 220, 10.1161/01.ATV.19.2.220 Bliss, 1993, A synaptic model of memory: long-term potentiation in the hippocampus, Nature, 361, 31, 10.1038/361031a0 Marianecci, 2010, Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts, J. Contr. Release, 147, 127, 10.1016/j.jconrel.2010.06.022 Corsaro, 2022, Development of Eudragit® nanoparticles for intranasal drug delivery: preliminary technological and toxicological evaluation, Appl. Sci., 12, 2373, 10.3390/app12052373 Anderson, 2003, Stability of mRNA/cationic lipid lipoplexes in human and rat cerebrospinal fluid: methods and evidence for nonviral mRNA gene delivery to the central nervous system, Hum. Gene Ther., 14, 191, 10.1089/10430340360535751 Lentz, 1989, Membrane “fluidity” as detected by diphenylhexatriene probes, Chem. Phys. Lipids, 50, 171, 10.1016/0009-3084(89)90049-2 Leskinen, 2012, Study of factors affecting the magnitude and nature of ultrasound exposure with in vitro set-ups, Ultrasound Med. Biol., 38, 777, 10.1016/j.ultrasmedbio.2012.01.019 Kinoshita, 2007, Key factors that affect sonoporation efficiency in in vitro settings: the importance of standing wave in sonoporation, Biochem. Biophys. Res. Commun., 359, 860, 10.1016/j.bbrc.2007.05.153 Hensel, 2011, Analysis of ultrasound fields in cell culture wells for in vitro ultrasound therapy experiments, Ultrasound Med. Biol., 37, 2105, 10.1016/j.ultrasmedbio.2011.09.007 Rose, 2014 Mango, 2016, Ginkgolic acid protects against aβ-induced synaptic dysfunction in the Hippocampus, Front. Pharmacol., 7, 10.3389/fphar.2016.00401 Shaarani, 2017, The Influence of pluronic F68 and F127 nanocarrier on physicochemical properties, in vitro release, and antiproliferative activity of thymoquinone drug, Phcog Res, 9, 12, 10.4103/0974-8490.199774 Migliore, 2010, Brain delivery of proteins by the intranasal route of administration: a comparison of cationic liposomes versus aqueous solution formulations, J Pharm Sci, 99, 1745, 10.1002/jps.21939 Danaei, 2018, Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems, Pharmaceutics, 10, 57, 10.3390/pharmaceutics10020057 Rinaldi, 2019, Hydrophilic silver nanoparticles loaded into niosomes: physical–chemical characterization in view of biological applications, Nanomaterials, 9, 1177, 10.3390/nano9081177 Cauzzo, 2020, Following the fate of dye-containing liposomes in vitro, IJMS, 21, 4847, 10.3390/ijms21144847 Frenzel, 2015, Whey protein coating increases bilayer rigidity and stability of liposomes in food-like matrices, Food Chem., 173, 1090, 10.1016/j.foodchem.2014.10.076 Ghernaout, 2015, Brownian motion and coagulation process, AJEP, 4, 1, 10.11648/j.ajeps.s.2015040501.11 Bhattacharjee, 2016, DLS and zeta potential – what they are and what they are not?, J. Contr. Release, 235, 337, 10.1016/j.jconrel.2016.06.017 Nakhaei, 2021, Liposomes: structure, biomedical applications, and stability parameters with emphasis on cholesterol, Front. Bioeng. Biotechnol., 9, 705886, 10.3389/fbioe.2021.705886 Biagioni, 2015 De Maar, 2021, Ultrasound-Mediated drug delivery with a clinical ultrasound system: in vitro evaluation, Front. Pharmacol., 12, 768436, 10.3389/fphar.2021.768436 Nigam, 2019, Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles, Drug Deliv. and Transl. Res., 9, 879, 10.1007/s13346-019-00622-5 Rinaldi, 2018, Chitosan glutamate-coated niosomes: a proposal for nose-to-brain delivery, Pharmaceutics, 10, 38, 10.3390/pharmaceutics10020038 Sharma, 2015, Self-degrading niosomes for encapsulation of hydrophilic and hydrophobic drugs: an efficient carrier for cancer multi-drug delivery, Mater. Sci. Eng. C, 56, 393, 10.1016/j.msec.2015.06.049 2010, Guidelines for the safe use of diagnostic ultrasound equipment, Ultrasound, 18, 52, 10.1258/ult.2010.100003 Apfel, 1991, Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound, Ultrasound Med. Biol., 17, 179, 10.1016/0301-5629(91)90125-G Ahmadi, 2013, A new mechanical index for gauging the human bioeffects of low frequency ultrasound, Annu Int Conf IEEE Eng Med Biol Soc, 2013, 1964 Marks, 2001, Amphiphilic, tri-block copolymers provide potent membrane-targeted neuroprotection, Faseb. J., 15, 1107 Di Maso, 1990, Determination of sorbitan trioleate in metered-dose inhalers by supercritical-fluid chromatography, J. Pharmaceut. Biomed. Anal., 8, 303, 10.1016/0731-7085(90)80042-N